INBS (Intelligent Bio Solutions) Other Stockholders Equity: $-0.00 Mil (As of Mar. 2026)


INBS Intelligent Bio Solutions Inc INBS
50 GF Score
Price $2.24
GF Value $2.59
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Intelligent Bio Solutions Other Stockholders Equity?

Intelligent Bio Solutions INBS -3.04% 50 Other Stockholders Equity is $-0.00 Mil as of Mar. 2026. GuruFocus rates INBS with a GF Score™ of 50/100 and a GF Value™ of $2.59 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Intelligent Bio Solutions's Other Stockholders Equity for the quarter that ended in Mar. 2026 was $-0.00 Mil.

Intelligent Bio Solutions's quarterly Other Stockholders Equity increased from Sep. 2025 ($-0.00 Mil) to Dec. 2025 ($0.00 Mil) but then declined from Dec. 2025 ($0.00 Mil) to Mar. 2026 ($-0.00 Mil).

Intelligent Bio Solutions's annual Other Stockholders Equity declined from Jun. 2023 ($-0.00 Mil) to Jun. 2024 ($-0.00 Mil) but then increased from Jun. 2024 ($-0.00 Mil) to Jun. 2025 ($0.00 Mil).

Intelligent Bio Solutions Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Intelligent Bio Solutions's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intelligent Bio Solutions Other Stockholders Equity Chart

Intelligent Bio Solutions Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -0.00 -0.00 0.00

Intelligent Bio Solutions Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 -0.00 0.00 -0.00
INBS
50GF Score
Intelligent Bio Solutions Inc INBS
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intelligent Bio Solutions Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.00 Mil mean?
Intelligent Bio Solutions (INBS) has a Other Stockholders Equity of $-0.00 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Intelligent Bio Solutions and its competitors.
Is Intelligent Bio Solutions' Other Stockholders Equity too high?
Intelligent Bio Solutions' current Other Stockholders Equity is $-0.00 Mil. Overall, Intelligent Bio Solutions has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Intelligent Bio Solutions' Other Stockholders Equity compare to ITOC and WOK?
Intelligent Bio Solutions' Other Stockholders Equity of $-0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Intelligent Bio Solutions and its competitors. Intelligent Bio Solutions's current Other Stockholders Equity is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intelligent Bio Solutions stock overvalued right now?
Based on GuruFocus' analysis, Intelligent Bio Solutions (INBS) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.59, compared to a current price of $2.24 — trading 13.5% below its estimated fair value. The current Other Stockholders Equity is $-0.00 Mil. Intelligent Bio Solutions' overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Intelligent Bio Solutions (INBS), the current Other Stockholders Equity is $-0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Intelligent Bio Solutions (INBS) Overvalued in 2026?

Based on GuruFocus' analysis, Intelligent Bio Solutions stock appears to be undervalued. The current stock price of $2.24 is trading 13.5% below its estimated GF Value™ of $2.59. GuruFocus considers Intelligent Bio Solutions to be Modestly Undervalued.

Key valuation signals for INBS:

  • Other Stockholders Equity: $-0.00 Mil
  • GF Value™: $2.59 vs. price of $2.24 (13.5% below fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the INBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Intelligent Bio Solutions Business Description

Address 135 West, 41ST Street, 5th Floor, New York, NY, USA, 10036
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
50GF Score

Get the complete analysis for INBS

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.24
Price
$2.59
GF Value